Adverse drug events (ADEs) are responsible for a significant number of hospital admissions and fatalities. Machine learning models have been developed to assess the individual patient risk of having an ADE. In this article, we have reviewed studies addressing the prediction of ADEs in observational health data with machine learning. The field of individualised ADE prediction is rapidly emerging through the increasing availability of additional data modalities (e.g., genetic data, screening data, wearables data) and advanced deep learning models such as transformers. Consequently, personalised adverse drug event predictions are becoming more feasible and tangible.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.drudis.2023.103715 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!